J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alcamí, A.
Right arrow Articles by Smith, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alcamí, A.
Right arrow Articles by Smith, G. L.
Agricola
Right arrow Articles by Alcamí, A.
Right arrow Articles by Smith, G. L.
Journal of General Virology (2002), 83, 545-549.
© 2002 Society for General Microbiology


Animal: DNA Viruses

The vaccinia virus soluble interferon-{gamma} receptor is a homodimer

Antonio Alcamía,1 and Geoffrey L. Smith1

Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK1

Author for correspondence: Geoffrey L. Smith. Present address: The Wright–Fleming Institute, Imperial College School of Medicine, St Mary’s Campus, Norfolk Place, London W2 1PG, UK. Fax +44 207 594 3973. e-mail glsmith{at}ic.ac.uk

The vaccinia virus (VV) interferon (IFN)-{gamma} receptor (IFN-{gamma}R) is a 43 kDa soluble glycoprotein that is secreted from infected cells early during infection. Here we demonstrate that the IFN-{gamma}R from VV, cowpox virus and camelpox virus exists naturally as a homodimer, whereas the cellular IFN-{gamma}R dimerizes only upon binding the homodimeric IFN-{gamma}. The existence of the virus protein as a dimer in the absence of ligand may provide an advantage to the virus in efficient binding and inhibition of IFN-{gamma} in solution.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. A. Nuara, L. J. Walter, N. J. Logsdon, S. I. Yoon, B. C. Jones, J. M. Schriewer, R. M. Buller, and M. R. Walter
Structure and mechanism of IFN-{gamma} antagonism by an orthopoxvirus IFN-{gamma}-binding protein
PNAS, February 12, 2008; 105(6): 1861 - 1866.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Ahmed, J. P. Martin, and H. M. Johnson
IFN Mimetic as a Therapeutic for Lethal Vaccinia Virus Infection: Possible Effects on Innate and Adaptive Immune Responses
J. Immunol., April 1, 2007; 178(7): 4576 - 4583.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. A. Nuara, H. Bai, N. Chen, R. M. L. Buller, and M. R. Walter
The Unique C Termini of Orthopoxvirus Gamma Interferon Binding Proteins Are Essential for Ligand Binding
J. Virol., November 1, 2006; 80(21): 10675 - 10682.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. M. I. Ahmed, M. A. Burkhart, P. S. Subramaniam, M. G. Mujtaba, and H. M. Johnson
Peptide Mimetics of Gamma Interferon Possess Antiviral Properties against Vaccinia Virus and Other Viruses in the Presence of Poxvirus B8R Protein
J. Virol., May 1, 2005; 79(9): 5632 - 5639.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. C. Reading and G. L. Smith
Vaccinia Virus Interleukin-18-Binding Protein Promotes Virulence by Reducing Gamma Interferon Production and Natural Killer and T-Cell Activity
J. Virol., September 15, 2003; 77(18): 9960 - 9968.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. B. Johnston and G. McFadden
Poxvirus Immunomodulatory Strategies: Current Perspectives
J. Virol., June 1, 2003; 77(11): 6093 - 6100.
[Full Text] [PDF]


Home page
JEMHome page
P. C. Reading, J. B. Moore, and G. L. Smith
Steroid Hormone Synthesis by Vaccinia Virus Suppresses the Inflammatory Response to Infection
J. Exp. Med., May 19, 2003; 197(10): 1269 - 1278.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. A. Symons, E. Adams, D. C. Tscharke, P. C. Reading, H. Waldmann, and G. L. Smith
The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model
J. Gen. Virol., November 1, 2002; 83(11): 2833 - 2844.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. A. Symons, D. C. Tscharke, N. Price, and G. L. Smith
A study of the vaccinia virus interferon-{gamma} receptor and its contribution to virus virulence
J. Gen. Virol., August 1, 2002; 83(8): 1953 - 1964.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
D. C. Tscharke, P. C. Reading, and G. L. Smith
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes
J. Gen. Virol., August 1, 2002; 83(8): 1977 - 1986.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2002 by the Society for General Microbiology.